… of drug regimens and quantifying exposure-response relationships (14, 15). Comprehensive
data sets exist for drugs used as monotherapy and in combination with others (27–33). …

… We investigated the access to genotypic and phenotypic Mycobacterium tuberculosis drug
… confirmed availability of the drug; b detailed regimen composition is shown in Table S1 …

… demonstrated for the first time that certain forms of drug-resistant tuberculosis can be cured
… these drugs may further advance optimized regimen compositions. Investigational drugs in …

… -line drug with bactericidal activity, has an important role in the treatment of both drug-susceptible
and drug-resistant tuberculosis. Although its role in the longer MDR-TB regimen has …

… focusing on drug safety of agents used in drug-sensitive TB … of drugs recommended for the
treatment of DR- and latent TB in … The recommended composition of treatment regimens for …

… DST and the costs and availability of anti-tuberculosis drugs and regimen, we performed a
… and ATS/CDC/IDSA/ERS 15 , whereas other regimen compositions could also be possible. …

… longer regimens to those whose composition met 2018 WHO guidelines by using at least
three drugs from group A (moxifloxacin/levofloxacin, bedaquiline, linezolid) plus at least one …

… drug-resistant tuberculosis drug susceptibility testing electrocardiogram Electronic … of
specific drug compositions and combinations of different regimen durations (3–12). Patients with …

… The 2020 WHO guidelines updated the composition of longer regimens for MDR/RR-TB with
a 3-group approach: Group A medicines are bedaquiline, levofloxacin or moxifloxacin, and …

… shorter regimens to individualized regimens of a longer composition, aligning with WHO
guidelines for MDR-TB treatment [8]. Ongoing research endeavors aim to discern the optimal …